» Authors » Anil Chandraker

Anil Chandraker

Explore the profile of Anil Chandraker including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 122
Citations 2853
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Halleck F, Bohmig G, Couzi L, Rostaing L, Einecke G, Lefaucheur C, et al.
Clin Transplant . 2024 Jul; 38(7):e15383. PMID: 39023092
Background: Antibody-mediated rejection (ABMR) poses a barrier to long-term graft survival and is one of the most challenging events after kidney transplantation. Removing donor specific antibodies (DSA) through therapeutic plasma...
2.
Schreiber B, Tripathi S, Nikiforow S, Chandraker A
Semin Nephrol . 2024 Mar; 44(1):151498. PMID: 38555223
Cancer is one of the most devastating complications of kidney transplantation and constitutes one of the leading causes of morbidity and mortality among solid organ transplantation (SOT) recipients. Immunosuppression, although...
3.
Chandraker A, Regmi A, Gohh R, Sharma A, Woodle E, Ansari M, et al.
J Am Soc Nephrol . 2024 Mar; 35(5):618-629. PMID: 38470444
No abstract available.
4.
Huck D, Weber B, Schreiber B, Pandav J, Parks S, Hainer J, et al.
Circ Cardiovasc Imaging . 2024 Jan; 17(1):e015858. PMID: 38227694
Background: Advanced chronic kidney disease is associated with high cardiovascular risk, even after kidney transplant. Pretransplant cardiac testing may identify patients who require additional assessment before transplant or would benefit...
5.
Raina R, Jothi S, Haffner D, Somers M, Filler G, Vasistha P, et al.
Kidney Int . 2023 Dec; 105(3):450-463. PMID: 38142038
Focal segmental glomerular sclerosis (FSGS) is 1 of the primary causes of nephrotic syndrome in both pediatric and adult patients, which can lead to end-stage kidney disease. Recurrence of FSGS...
6.
Huck D, Buckley L, Chandraker A, Blankstein R, Weber B
J Cardiovasc Pharmacol . 2023 Sep; 83(6):511-521. PMID: 37678318
Inflammation is an important contributor to excess cardiovascular risk and progressive renal injury in people with chronic kidney disease (CKD). Dysregulation of the innate and adaptive immune system is accelerated...
7.
Ueno T, Ikeda T, Okihara M, Akashi I, Yokoyama T, Kihara Y, et al.
Front Med (Lausanne) . 2023 Apr; 10:1042487. PMID: 37007795
Background: Early recovery from shock improves prognosis in septic shock patients. We determined whether cytokine modulation by Continuous Renal Replacement Therapy (CRRT) following acute care surgery resulted in stable hemodynamics...
8.
Heo S, Park Y, Lee N, Kim Y, Kim Y, Shin H, et al.
Transplant Proc . 2022 Oct; 54(8):2117-2124. PMID: 36192209
Background: We evaluated the efficacy and safety of eculizumab in comparison with plasmapheresis and intravenous immunoglobulin therapy in renal transplant recipients diagnosed with antibody-mediated rejection (AMR). Methods: This was a...
9.
Chandraker A
Semin Nephrol . 2022 May; 42(1):1. PMID: 35618391
No abstract available.
10.
Tripathi S, Martin-Moreno P, Kavalam G, Schreiber B, Waaga-Gasser A, Chandraker A
Front Immunol . 2022 Apr; 13:849939. PMID: 35371066
Regulatory T cells are an important component of an immune response shaping the overall behavior to potential antigens including alloantigens. Multiple mechanisms have been shown to contribute towards developing and...